Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149682337> ?p ?o ?g. }
- W2149682337 endingPage "492" @default.
- W2149682337 startingPage "484" @default.
- W2149682337 abstract "The prognostic impact of immunophenotypic markers in acute myeloid leukemia (AML) is controversial.We retrospectively analyzed the value of CD34, CD117, CD7, and CD123 expression in a consecutive series of 592 adult patients with de novo AML.CD34+ measured as a percentage (≥2.88%) and CD34 mean fluorescence intensity (MFI) (≥146.79, arbitrary units [AU]) expression had a prognostic impact in terms of overall survival (OS; P = .005, P = .003), leukemia-free survival (LFS; P = .011, P < .001), and cumulative incidence of relapse (CIR; P = .014, P =. 001). The percentage of CD117+ cells (61.29%) was associated with shorter LFS (P =. 043), and CD117 MFI (≥284.01 AU) was associated with a shorter OS (P =. 033) and LFS (P =. 028). In the multivariate analysis, high CD34 MFI retained the independent value as predictor of LFS and CIR (P =. 012; hazard ratio [HR], 1.59; 95% confidence interval [CI], 1.11-2.28 and P =. 045; HR, 1.58; 95% CI, 1.01-2.46).CD34 positivity threshold with prognostic relevance is low (3% positive cells). Immunophenotypic findings in AML probably could only be fully exploited after a complex analysis that takes into account unconventional thresholds and the MFI." @default.
- W2149682337 created "2016-06-24" @default.
- W2149682337 creator A5000942690 @default.
- W2149682337 creator A5006173909 @default.
- W2149682337 creator A5006887524 @default.
- W2149682337 creator A5010010012 @default.
- W2149682337 creator A5017225753 @default.
- W2149682337 creator A5017967907 @default.
- W2149682337 creator A5025528565 @default.
- W2149682337 creator A5027357638 @default.
- W2149682337 creator A5030524681 @default.
- W2149682337 creator A5035866456 @default.
- W2149682337 creator A5051937379 @default.
- W2149682337 creator A5059808568 @default.
- W2149682337 creator A5062943407 @default.
- W2149682337 creator A5076623303 @default.
- W2149682337 creator A5082803634 @default.
- W2149682337 creator A5084354003 @default.
- W2149682337 creator A5084819549 @default.
- W2149682337 creator A5085817630 @default.
- W2149682337 creator A5088424162 @default.
- W2149682337 date "2015-09-01" @default.
- W2149682337 modified "2023-10-18" @default.
- W2149682337 title "Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML" @default.
- W2149682337 cites W1255676896 @default.
- W2149682337 cites W1562680005 @default.
- W2149682337 cites W1723032639 @default.
- W2149682337 cites W1973256635 @default.
- W2149682337 cites W1987502130 @default.
- W2149682337 cites W2004338378 @default.
- W2149682337 cites W2017660057 @default.
- W2149682337 cites W2023381080 @default.
- W2149682337 cites W2028231895 @default.
- W2149682337 cites W2028521588 @default.
- W2149682337 cites W2034409643 @default.
- W2149682337 cites W2038981426 @default.
- W2149682337 cites W2045859956 @default.
- W2149682337 cites W2048015101 @default.
- W2149682337 cites W2048385227 @default.
- W2149682337 cites W2056148612 @default.
- W2149682337 cites W2065464763 @default.
- W2149682337 cites W2067350868 @default.
- W2149682337 cites W2070976881 @default.
- W2149682337 cites W2071472421 @default.
- W2149682337 cites W2075808651 @default.
- W2149682337 cites W2081888771 @default.
- W2149682337 cites W2083645498 @default.
- W2149682337 cites W2090630520 @default.
- W2149682337 cites W2093144236 @default.
- W2149682337 cites W2101157786 @default.
- W2149682337 cites W2107398329 @default.
- W2149682337 cites W2111121001 @default.
- W2149682337 cites W2116858301 @default.
- W2149682337 cites W2124593264 @default.
- W2149682337 cites W2126212760 @default.
- W2149682337 cites W2144395887 @default.
- W2149682337 cites W2150065770 @default.
- W2149682337 cites W2150113701 @default.
- W2149682337 cites W2159507916 @default.
- W2149682337 cites W2257838202 @default.
- W2149682337 cites W2313410650 @default.
- W2149682337 cites W3111770416 @default.
- W2149682337 cites W4376595466 @default.
- W2149682337 cites W69990049 @default.
- W2149682337 doi "https://doi.org/10.1309/ajcprl6xsvfmlh9v" @default.
- W2149682337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26276779" @default.
- W2149682337 hasPublicationYear "2015" @default.
- W2149682337 type Work @default.
- W2149682337 sameAs 2149682337 @default.
- W2149682337 citedByCount "14" @default.
- W2149682337 countsByYear W21496823372016 @default.
- W2149682337 countsByYear W21496823372017 @default.
- W2149682337 countsByYear W21496823372020 @default.
- W2149682337 countsByYear W21496823372021 @default.
- W2149682337 countsByYear W21496823372022 @default.
- W2149682337 crossrefType "journal-article" @default.
- W2149682337 hasAuthorship W2149682337A5000942690 @default.
- W2149682337 hasAuthorship W2149682337A5006173909 @default.
- W2149682337 hasAuthorship W2149682337A5006887524 @default.
- W2149682337 hasAuthorship W2149682337A5010010012 @default.
- W2149682337 hasAuthorship W2149682337A5017225753 @default.
- W2149682337 hasAuthorship W2149682337A5017967907 @default.
- W2149682337 hasAuthorship W2149682337A5025528565 @default.
- W2149682337 hasAuthorship W2149682337A5027357638 @default.
- W2149682337 hasAuthorship W2149682337A5030524681 @default.
- W2149682337 hasAuthorship W2149682337A5035866456 @default.
- W2149682337 hasAuthorship W2149682337A5051937379 @default.
- W2149682337 hasAuthorship W2149682337A5059808568 @default.
- W2149682337 hasAuthorship W2149682337A5062943407 @default.
- W2149682337 hasAuthorship W2149682337A5076623303 @default.
- W2149682337 hasAuthorship W2149682337A5082803634 @default.
- W2149682337 hasAuthorship W2149682337A5084354003 @default.
- W2149682337 hasAuthorship W2149682337A5084819549 @default.
- W2149682337 hasAuthorship W2149682337A5085817630 @default.
- W2149682337 hasAuthorship W2149682337A5088424162 @default.
- W2149682337 hasBestOaLocation W21496823371 @default.
- W2149682337 hasConcept C10205521 @default.
- W2149682337 hasConcept C126322002 @default.